Janux TherapeuticsJANX

那斯達克 · USD
19.43
-0.61
(-3.04%)
盤中 09/10 02:34 (UTC+8)
09/10 02:34 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.01
  • 0.09
  • 0.00
  • -
  • -
  • -
  • 0.10
  • -
  • 0.04
  • 0.10
icon
  • -49.13
  • 610.62
  • -95.07
  • -
  • -
  • -
  • -
  • -
  • -
  • 175.03
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
10,267
3,733
-
10,000
-
-
-
439
8,897
1,252
營業成本
----------
營業毛利
10,267
3,733
-
10,000
-
-
-
439
8,897
1,252
營業費用
41,95737,94642,40145,25145,11834,89729,02236,281-21,413
研發費用
30,99426,81331,54834,62934,66425,05520,80618,61414,89814,070
推銷及管理費用
10,96311,13310,85310,62210,4549,8428,21617,6677,8217,343
非經常性項目費用
----------
其他營業費用
----------
營業利益
-31,690
-34,213
-42,401
-35,251
-45,118
-34,897
-29,022
-35,842
-13,822
-20,161
其他收入及費用
9,7189,85210,45510,93811,26011,3898,8067,7837,8635,401
利息費用
----------
稅前純益
-21,972
-24,361
-31,946
-24,313
-33,858
-23,508
-20,216
-28,059
-5,959
-14,760
所得稅
----------
稅後純益
-21,972
-24,361
-31,946
-24,313
-33,858
-23,508
-20,216
-28,059
-5,959
-14,760
基本每股稅後盈餘(元)
-0.35-0.39-0.51-0.39-0.55-0.38-0.36-0.51-0.11-0.30
稀釋每股稅後盈餘(元)
-0.35-0.39-0.51-0.39-0.55-0.38-0.35-0.53-0.10-0.30
基本平均股數(千股)
62937.0062665.0062145.0062023.0061902.0061791.0056832.0054628.0054451.0049049.00
稀釋平均股數(千股)
62937.0062665.0062145.0062023.0061902.0061791.0056832.0054628.0054451.0049049.00
還原基本每股稅後盈餘(元)
-0.35-0.39-0.51-0.39-0.55-0.38-0.36-0.51-0.11-0.30
還原稀釋每股稅後盈餘(元)
-0.35-0.39-0.51-0.39-0.55-0.38-0.35-0.53-0.10-0.30
還原基本平均股數(千股)
62,93762,66562,14562,02361,90261,79156,83254,62854,45149,049
還原稀釋平均股數(千股)
62,93762,66562,14562,02361,90261,79156,83254,62854,45149,049
EBITDA(千元)
-24,395-26,516-35,002-28,435-38,523-27,210-22,631-30,447-8,426-16,015

大家都在看

HOT